Cargando…
Evidence-based treatment during the SARS-CoV-2 pandemic: Identifying the knowns and unknowns of nebulization
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus 19 (COVID-19), has resulted in a worldwide pandemic and currently represents a major public health issue. Among the considerations for patients with respiratory disease is the optimal delivery of inhaled bronchodi...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc. on behalf of the American Pharmacists Association.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524663/ https://www.ncbi.nlm.nih.gov/pubmed/33160867 http://dx.doi.org/10.1016/j.japh.2020.09.014 |